Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ENTA Enanta Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $12.20 -2.6% | $15.06 -2.0% |
| StockIQ Score | 37F Weak Risk: High | 36F Weak Risk: Medium |
| Technical | 13F | 13F |
| Fundamental | 30F | 35F |
| Growth | 68B- | 50C- |
| Fair Value | 55C | 38F |
| News | 32F | 50C- |
| Quality | 42D | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Enanta Pharmaceuticals (ENTA) outperforms Ascentage Pharma (AAPG) in nearly every category. Its technical score (74 vs. 18) and growth score (68 vs. 50) are significantly stronger, while AAPG’s weak investor score (37 vs. 52) and lower valuation (55 vs. 38) put it at a disadvantage. Only fundamental scores are close, but Enanta’s moderate overall rating contrasts sharply with AAPG’s weak one.
